Cornelius Ohonsi

Datos Biográficos

ID9067486
NOMBRECornelius Ohonsi
NOMBRESCornelius
APELLIDOOhonsi
FIRMAOHONSI C
AFILIACIONESNigeria Centre for Disease Control
ORCID0000-0002-4727-6835
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Performance evaluation of Sars-CoV-2 rapid diagnostic tests in Nigeria

    Open AccessAkhere A Omonkhua, Adedayo Omotayo FANEYE et al.ARTICLEPLOS Global Public Health2024

    The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative eva…

  • Covid-19 mortality rate and its associated factors during the first and second waves in Nigeria

    Open AccessKelly Elimian, Anwar Musah et al.ARTICLEPLOS Global Public Health2022

    COVID-19 mortality rate has not been formally assessed in Nigeria. Thus, we aimed to address this gap and identify associated mortality risk factors during the first and second waves in Nigeria. This was a retrospective analysis of national surveillance data from all 37 States in Nigeria between February 27, 2020, and April 3, 2021. The outcome variable was mortality amongst persons who tested positive for SARS-CoV-2 by Reverse-Transcriptase Poly…

  • Covid-19 vaccine effectiveness studies in Nigeria

    Open AccessOluwatosin Wuraola Akande, Oluwatosin Akande et al.ARTICLEJournal of Global Health2022

    The “lickety–split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was first sequenced is indeed one of the public health successes of the 21st century. Particularly because an 18-month target was initially considered reasonable, and having achieved this success, a “moonshot” goal to ensure that a vaccine is available within 100 days [...]

  • Epidemiological comparison of the first and second waves of the Covid-19 pandemic in Nigeria, February 2020–April 2021

    Open AccessOluwatosin Akande, Kelly Elimian et al.ARTICLEBMJ Global Health2021

    BACKGROUND: With reports of surges in COVID-19 case numbers across over 50 countries, country-level epidemiological analysis is required to inform context-appropriate response strategies for containment and mitigation of the outbreak. We aimed to compare the epidemiological features of the first and second waves of COVID-19 in Nigeria. METHODS: We conducted a retrospective analysis of the Surveillance Outbreak Response Management and Analysis Sys…